A University of North Carolina at Chapel Hill spin-off company has been awarded a $2 million grant to commercialize a new technology to improve radiation treatment of prostate cancer.
The grant from the National Cancer Institute, as part of its Small Business Innovation Research program, will enable Morphormics Inc. to market its proprietary technology for rapidly constructing anatomical “roadmaps” of individual patients.
“These roadmaps are critical navigational aids that help physicians keep a radiation beam focused on the tumor, while at the same time avoiding nearby parts of the body that could be harmed by radiation exposure,” said Edward L. Chaney, Ph.D., Morphormics’ vice president of technology, professor in the School of Medicine’s department of radiation oncology, and member of the UNC Lineberger Comprehensive Cancer Center.
source: UNC News
Monday, September 8, 2008
UNC spin-off company receives $2 million grant to market cancer treatment technology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment